Clinical Trials Logo

Neurotic Disorders clinical trials

View clinical trials related to Neurotic Disorders.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03036293 Completed - Anxiety Clinical Trials

Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders

Start date: February 8, 2017
Phase: Phase 4
Study type: Interventional

The purposes of this study are: - To further examine the efficacy and safety of Tenoten® in the treatment of anxiety in patients with somatoform, stress-related and other neurotic disorders. - To compare the efficacy of two dosing regimens of Tenoten® (4 tablets daily vs.8 tablets daily, both for 12 weeks) in the treatment of anxiety in patients with somatoform, stress-related and other neurotic disorders.

NCT ID: NCT02308462 Completed - Clinical trials for Substance-Related Disorders

Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents

CHIMPs
Start date: November 2014
Phase: N/A
Study type: Interventional

In order to identify psychological stress in children and adolescents of mentally ill parents as early as possible, a special intervention program (CHIMPs = Children of mentally ill parents) was developed. The study at hand will implement this intervention program at five sites in Germany and will further evaluate its effectiveness. The CHIMPs intervention is assumed to reduce children's psychopathology and enhance their health related quality of life.

NCT ID: NCT01226511 Completed - Anxiety Neuroses Clinical Trials

A Study in Pediatric Participants With Generalized Anxiety Disorder

Start date: June 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to find out if duloxetine [30-120 milligrams (mg)] given once a day by mouth for 10 weeks to children and adolescents, is better than placebo when treating Generalized Anxiety Disorder (GAD).

NCT ID: NCT00269594 Completed - Clinical trials for Obsessive-Compulsive Disorder

An Open-Label Study Of Lamictal In Neurotic Excoriation

Start date: January 2006
Phase: Phase 2
Study type: Interventional

The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label treatment with Lamictal. The hypothesis to be tested is that Lamictal will be effective and well tolerated in patients with neurotic excoriation. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.